Editorial: Clinical implementation of precision oncology data to direct individualized and immunotherapy-based treatment strategies

• Nicholas A. Young,
• Nicholas A. Young,
• Nicholas A. Young,
• Jenifer R. Prosperi,
• Jenifer R. Prosperi,
• Jenifer R. Prosperi,
• Aharon G. Freud,
• Nelson S. Yee,
• Nelson S. Yee,
• Emanuel F. Petricoin,
• Emanuel F. Petricoin

Affiliations

Nicholas A. Young

Division of Rheumatology and Immunology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States

Nicholas A. Young

More than Moore’s Precision Medicine Solutions (MtM), Columbus, OH, United States

Nicholas A. Young

Private Health Management (PHM), Los Angeles, CA, United States

Jenifer R. Prosperi

Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, United States

Jenifer R. Prosperi

Harper Cancer Research Institute, South Bend, IN, United States

Jenifer R. Prosperi

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, South Bend, IN, United States

Aharon G. Freud

Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, United States

Nelson S. Yee

Division of Hematology-Oncology, Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA, United States

Nelson S. Yee

Next-Generation Therapies Program, Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, United States

Emanuel F. Petricoin

0Ignite Proteomics Inc., Golden, CO, United States

Emanuel F. Petricoin

1Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States